The aforementioned findings confirmed that Tri-NAb facilitated the substantial activation and proliferation of NK and CD8+ T cells, augmented the interaction between NK/CD8+ T cells and tumor cells, and strengthened innate and adaptive antitumor immune responses. The gene discussed is CD8A; the disease is neoplasm.